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Less than ﬁve years ago, the zebraﬁsh swam into
the limelight as a model genetic organism, with the
description of hundreds of mutant phenotypes from
screens in Boston and Tu ¨bingen (Development 123,
1996). Since that time, much of the zebraﬁsh
research community has focussed on identifying
the chemically-induced mutations responsible for
these phenotypes and on improving zebraﬁsh
genomic tools and resources. Other researchers
have embarked on new mutant screens, while still
others have continued to exploit the amenability
of zebraﬁsh embryos to surgical manipulation
and microscopic imaging to address questions
at the cellular level. Annual conferences on zebra-
ﬁsh development and genetics have provided
impressive snapshots of the progress made in these
various directions and others, and this year’s
Second European Conference on Zebraﬁsh Genetics
and Development, which took place from April
19–22 at University College of London, was no
exception.
Identiﬁcation of mutations
A number of speakers announced the identiﬁca-
tion of mutated genes causing speciﬁc phenotypes.
In separate talks, T. Dickmeis (Strasbourg) and
H. Verkade (San Francisco) revealed that casanova
mutants, which lack endoderm and display cardia
biﬁda, bear a mutation in a gene related to the SoxF
family of transcription factors. E. Walsh (San
Francisco) showed that the branchial arch defects
of jekyll mutants and their failure to form an
atrioventricular valve in the heart or semicircular
canals in the ear result from mutation of an enzyme
involved in glycosaminoglycan synthesis, and
S. Horne (San Francisco) demonstrated that muta-
tion of a protein kinase gene likely to be involved in
cell polarity causes the defective morphogenesis of
the heart, eye and visceral organs seen in heart and
soul mutants. Eye defects are also seen in lakritz
mutants, which lack retinal ganglion cells while
displaying an excess of other classes of retinal
neurons and glia, and J. Kay (San Francisco)
showed that this phenotype arises from a mutation
in ath5, a zebraﬁsh homologue of the transcription
factor atonal, leading to misallocations of retinal
cell fate. In a ‘guest ﬁsh’ talk, J. Wittbrodt
(Heidelberg) described medaka eyeless mutants,
which have a failure in eye evagination, and
provided evidence that this phenotype results from
the disruption of a homeobox gene. D. Kozlowski
(Philadelphia) showed that dog-eared mutants,
which do not form cristae in the inner ear, and
which have reduced numbers of hair cells and
lateral line neuromasts, have a mutation in the
eyes absent-1 gene. H. Grandel (Heidelberg/Dresden)
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ﬁns and cartilaginous gill arches, and presented evi-
dence that no ﬁn bears a mutation in a retinoic acid
biosynthetic enzyme. Finally, two speakers, W.
Driever (Freiburg) and G. Reim (Heidelberg/Dresden)
independently revealed that mutation of a POU-
domain transcription factor causes the phenotype
seen in spiel ohne grenzen mutants, which fail to
establish a mid-hindbrain boundary (MHB) and
display severe mid- and hindbrain defects. In
summary, the cloning of a variety of zebraﬁsh
mutations has opened new windows on biochemical
pathways responsible for germ layer formation,
heart, eye and ear development, regionalization of
the brain and other developmental processes.
New genetic screens
The original screen in Tu ¨bingen was very large
scale, with 3857 mutagenized genomes screened
(2746 F2 families), but this was surpassed by the
y5000 genomes screened in the recently completed
‘Tu ¨bingen 2000’ screen by Artemis Pharmaceuticals
(co-founded in 1998 by C. Nu ¨sslein-Vollhard and
K. Rajewsky) and collaborators. More important
than size, perhaps, new screening criteria were
employed, and sperm samples from each F1 male
were stored for future use. Initial results on one
component of this screen, focusing on vasculo-
genesis and angiogenesis, were presented by
H. Habeck (Tu ¨bingen). Embryonic vasculature was
visualized with alkaline phosphatase and over 700
mutants were obtained, falling into four broad
classes: those lacking major vessels, those lacking
secondary vessels, those with supernumerary vessels
and those displaying abnormal vessel morphology.
In addition, K. Dooley (Boston) and C. Klisa
(Heidelberg/Dresden) presented posters on the
results of collaborations with Artemis to identify
new hematopoeisis mutants and new brain de-
velopment mutants, respectively. In the hemato-
poeisis screen, a number of mutants with altered
expression of the hemangioblast marker scl were
obtained, as well as over 100 mutants with
decreased numbers of erythrocytes. In the brain
development screen, more than 200 mutants
were obtained in a variety of phenotypic classes.
Four classes were presented, namely mutants with
malformations in either the midbrain alone, fore-
and midbrain together or in the caudal hindbrain,
and mutants with enlarged telencephalons. Results
from various smaller-scale screens were also pre-
sented. For instance, R. Dosch (Philadelphia)
described a four generation screen for maternal-
effect genes. Because homozygous recessive females
are required for this screen, the isolated mutations
cannot be zygotically required for female survival
or fertility. Despite this limitation, 24 maternal-
effect mutants were isolated, displaying defects in
either chorion elevation, egg activation, general cell
survival, gastrulation movements, axial patterning
or primordial germ cell development. Y. Grinblat
(Boston) introduced results from a clever one-
generation screen that combines insertional muta-
genesis and haploid screening. Eggs from females
mutagenized with an insertional vector were acti-
vated with non-functional sperm and grown as
haploid embryos. Such embryos were screened for
defects in early brain morphology and alterations in
neurectoderm marker staining patterns at the neural
plate stage, and 19 founder females were identiﬁed
that transmit defects speciﬁc to the forebrain,
midbrain or hindbrain. Because the mutagen pro-
vides a tag, the cloning of these mutations is
potentially straightforward, and is already under-
way. To conclude, genetic screens continue to
generate a variety of interesting new mutants, and
the study of these mutants is likely to fuel future
research in such areas as vascular, hematopoetic
and neural development.
A zebraﬁsh genome project
The challenge of cloning the growing number of
zebraﬁsh mutants will be vastly facilitated by major
advances in the state of zebraﬁsh genomics, which
have already begun. Most noteworthy is the Well-
come Trust’s decision to fund the sequencing of the
zebraﬁsh genome by the Sanger Centre,a s
announced in October 2000. J. Rogers (Hinxton)
described the Sanger Centre’s rationale and sequen-
cing strategy. In addition to its obvious beneﬁt to
zebraﬁsh research, comparison of this lower verte-
brate sequence with those of mouse and man will
likely help to identify evolutionarily conserved
regions of non-coding DNA with important func-
tions. Sequencing is already underway and will soon
be at full capacity. For this initial phase, a whole-
genome shotgun strategy is being used, with 3X
coverage of the y1.7 Gb genome estimated to be
completed by December. All primary trace data will
be publicly available through the Sanger Centre’s
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are already available. Because of the mathematical
obstacle of assembling millions of non-anchored
sequence fragments into contigs, mapped clones will
be sequenced in a second phase, estimated to be
completed by October 2003. A key resource for this
second phase will be the physical map that is being
collaboratively assembled by the Max Planck
Institute in Tu ¨bingen and the Hubrecht laboratory
in Utrecht. G.-J. Rauch (Tu ¨bingen) described their
approach. Clones (averaging 90 to 165 Kb in size)
from bacterial artiﬁcial chromosome (BAC)
libraries are digested to reveal restriction enzyme
ﬁngerprints, and commonalties between ﬁngerprints
of overlapping clones are identiﬁed by analytical
software developed at the Sanger Centre. Using
state-of-the art tools for ongoing high throughput
and analysis, well over 100 000 BACs (to achieve
>10-fold coverage of the genome) will be
assembled into minimum tiling paths. At the time
of the conference, 25 810 BACs had already been
analyzed, 11 447 of which had been assigned to
3254 contigs. A further goal at the MPI in
Tu ¨bingen is to anchor the resulting physical map
to a recombinant hybrid panel that is already
signiﬁcantly anchored to a high-resolution meiotic
map, thereby allowing the rapid and convenient
identiﬁcation of BAC clones near mapped muta-
tions. Thus, within a few short years zebraﬁsh
research will be in its post-genomic phase and the
task of positionally cloning mutations will be
dramatically eased.
Reverse genetics in zebraﬁsh
Zebraﬁsh research has been hampered by the
inability to directly assess the genetic function of
cloned genes, as is routinely done in mice using
knock-out technology or in Drosophila by P-
element insertion. This obstacle is now being
removed. In collaboration with Artemis pharma-
ceuticals, members of the Hubrecht laboratory have
demonstrated the feasibility of pre-screening F1
founder ﬁsh by brute-force sequencing to identify
carriers of speciﬁc mutations. R. Plasterk (Utrecht)
described this pilot study. In the Artemis screen,
tissue samples from each of the F1 founders were
routinely stored in addition to sperm. Using primers
spanning a large portion of the zebraﬁsh RAG1
gene, a crucial gene for the establishment of the
immune repertoire, DNA isolated from tissue of
each of 2687 F1 founders was PCR ampliﬁed and
sequenced, leading to the identiﬁcation of carriers
of 13 mutant alleles. Three of these alleles had silent
mutations, 10 had amino acid changes and one had
a premature stop codon. Though daunting in
appearance, this approach is surprisingly feasible if
an F1 sperm and DNA library is available: reagent
costs were under $10 000; the sequencing took one
month on a standard ABI sequencer; and fertile
carriers can be established from sperm stocks within
three months. Luckily, an alternative approach for
assessing the function of cloned genes has recently
emerged that is much cheaper and much faster,
though perhaps less deﬁnitive from a genetic
standpoint: the use of antisense morpholino oligo-
nucleotides (MOs) to inhibit translation of targeted
RNA. One year ago, at the Zebraﬁsh Genetics and
Development Meeting at Cold Spring Harbor,
A. Nasevicius and S. Ekker (Minneapolis) presented
a poster on the use of MOs in zebraﬁsh. This year
16 of 56 talks and numerous posters included MO
data, testifying to their robust utility in zebraﬁsh. In
many cases, MOs were used to conﬁrm an essential
role for mutated alleles linked to mutant pheno-
types. This was done by recapitulating these
phenotypes in wild type embryos injected with
MOs targeted to the gene in question. In some
cases MOs were used in advance of mutant allele
sequencing, in order to ﬁrst identify which of
several candidate genes could be inhibited to
produce the mutant phenotype in question. In this
way, MOs are facilitating the cloning of mutations
by saving time and increasing conﬁdence in the
identiﬁcation of candidate genes. Of course MOs
are also being used to investigate the phenotypic
consequences of removing genes of unknown func-
tion, and certain presentations that included this
approach are reviewed in the next section. Thus,
reverse genetics has ﬁnally arrived in zebraﬁsh.
Considering that the sequence of every zebraﬁsh
gene will soon be available, the timing couldn’t be
better.
New genes and their functions
A number of interesting new genes were intro-
duced in this year’s conference, and using MOs it
was often possible to complement data on their
expression patterns and misexpression phenotypes
with the consequences of their inhibition. C. Houart
(London) built upon her previous identiﬁcation of
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boundary with her identiﬁcation of a WNT ant-
agonist that is speciﬁcally expressed in these cells
and which can confer forebrain-inducing activity to
naive cells. MO inhibition of this gene leads to
forebrain deﬁciencies, and reciprocal brain defects
were seen when a WNT gene was ectopically
expressed, or inhibited with MOs. These studies
reveal an essential role for WNT signaling in
repressing forebrain development. Also contri-
buting to the understanding of brain patterning,
L. Bally-Cuif (Munich) described the isolation of
bts1, a zebraﬁsh gene with homology to Drosophila
buttonhead . Expression of bts1 is conﬁned to the
MHB after gastrulation. Misexpression of bts1 can
induce ectopic pax2.1, which is normally conﬁned
to the MHB, and MO inhibition of bts1 blocks the
early expression of pax2.1. Therefore, bts1 is an
early regulator of pax2.1. Relatively few genes have
been described that are speciﬁc to ventral ectoderm
and the development of epidermis, so J. Bakkers’
(Freiburg) talk on p63, a p53-related transcriptional
repressor involved in ectodermal patterning, was a
welcome addition. p63 is expressed in the epidermal
precursor domain (ventral ectoderm) during gastrula-
tion, and its overexpression expands this domain.
Consistent with a role in epidermal development, MO
inhibition of p63 causes skin lesions in larvae.
Intriguingly, p63 MOs also block pectoral ﬁn bud
outgrowth and FGF8 expression in the apical
ectodermal ridge.
Bringing the tools together
One of the great attractions of studying zebraﬁsh is
they are nice to look at, and several talks that
featured in vivo imaging served as a reminder of
this. P. Herbomel (Paris) presented video recordings
documenting movements of early macrophages.
These macrophages spread into cephalic mesen-
chyme, invade adjacent epithelial tissues (brain,
retina and epidermis) and then display a wandering
behavior as if they are scavenging. In panther
mutants, which lack a functional macrophage
colony stimulating factor (M-CSF) receptor, macro-
phages fail to invade epithelial tissues, suggesting
the possibility that M-CSF serves as a chemo-
attractant that triggers invasive behavior. T.
Yoshida (Tokyo) presented particularly elegant stu-
dies that employed a tissue-speciﬁc promoter to drive
tau-eGFP (Green Fluorescent Protein) expression in
olfactory sensory neurons of transgenic embryos,
and visualized the pathﬁnding behavior of these
neurons, using confocal microscopy. Pathﬁnding
behavior was then compared between embryos
carrying transgenes that had been additionally
engineered to either enhance or repress protein
kinase A (PKA) signaling. In this way, distinct
olfactory sensory neuron pathﬁnding behaviors
were correlated to PKA signaling levels, suggesting
a native role for PKA signaling in modulating
pathﬁnding behavior. This use of eGFP vectors for
high-resolution cellular analysis in the context of
transparent zebraﬁsh embryos is particularly excit-
ing, but the generation of transgenic lines of
zebraﬁsh remains inefﬁcient. Promisingly, prelimi-
nary data from K. Kawakami (Tokyo) indicates that
inclusion of cis sequences from the medaka Tol2
transposable element in eGFP vectors can signiﬁ-
cantly enhance their germ-line integration when co-
injected with Tol2 transposase. Thus, by combining
genetic alterations with high quality imaging,
increasingly reﬁned questions are being asked. In a
similar way, cellular transplantation can be used to
juxtapose cells with distinct genetic conditions. For
instance, N. David (Paris) demonstrated that
expression of Tar* (a constitutively active form of
the ALK4 Nodal receptor) in donor cells causes
them to join the host endoderm and acquire an
endodermal fate. This fate induction/competence
restriction does not rely on signals from host
endoderm, however, as Tar*-expressing donor cells
also differentiate as endoderm in casanova mutant
hosts, which are devoid of endogenous endoderm.
Finally, Y. Chen (New York) demonstrated that the
zebraﬁsh Nodal protein Squint, but not Cyclops,
can behave as a morphogen. First, three genes
expressed in response to Nodal signals were shown
to respond to ectopic Squint in a graded manner,
and secondly, Squint was shown to elicit long
distance responses in either Nodal-deﬁcient
embryos (sqt;cyc double mutants) or Nodal-non-
responsive embryos (Maternal-Zygotic one-eyed
pinhead) harboring a small group of transplanted
responsive cells. Thus, it is becoming easier to
distinguish possible mechanisms of cellular
induction by comparing the responses of wild-
type and mutant hosts to grafts or misexpressed
constructs.
In conclusion, while the Second European Con-
ference on Zebraﬁsh Genetics and Development
will certainly be remembered as the meeting where
the zebraﬁsh genome project was inaugurated,
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and where J. Topczewski’s (Nashville) talk was
interrupted by two ﬁre evacuations, it was also
memorable for the broad range of excellent science
and the increasing sophistication of experimental
approaches.
The Meeting Reviews of Comparative and Functional Genomics aim to present a commentary on the topical
issues in genomics studies presented at a conference. These reviews are invited and each represents a
personal critical analysis of the current reports and aim at providing implications for future genomics
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